MedPath

山东希尔康泰药业有限公司

Ownership
-
Established
1999-04-02
Employees
-
Market Cap
-
Website
http://www.china-xekt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Amoxicillin Sodium for Injection

Product Name
注射用阿莫西林钠
Approval Number
国药准字H20123326
Approval Date
Aug 17, 2022
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and chlorphenamine Maleate capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H37023374
Approval Date
Jan 16, 2020
NMPA

Galculus Bovis and Metronidazole Capsules

Product Name
人工牛黄甲硝唑胶囊
Approval Number
国药准字H37023375
Approval Date
Jan 16, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H37020836
Approval Date
Jan 16, 2020
NMPA

Piperazine Ferulate Dispersible Tablets

Product Name
阿魏酸哌嗪分散片
Approval Number
国药准字H20052333
Approval Date
Jan 16, 2020
NMPA

Sterile Water for Injection

Product Name
灭菌注射用水
Approval Number
国药准字H20094021
Approval Date
Aug 30, 2019
NMPA

空心胶囊

Approval Number
国药准字F20050028
Approval Date
Jul 2, 2005
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.